The DOI matches its Crossref record; 55 of the 55 references it cites were found in a registry or an index.
CTLs are targeted to kill β cells in patients with type 1 diabetes through recognition of a glucose-regulated preproinsulin epitope
Open accessAbstract
The final pathway of beta cell destruction leading to insulin deficiency, hyperglycemia, and clinical type 1 diabetes is unknown. Here we show that circulating CTLs can kill beta cells via recognition of a glucose-regulated epitope. First, we identified 2 naturally processed epitopes from the human preproinsulin signal peptide by elution from HLA-A2 (specifically, the protein encoded by the A*0201 allele) molecules. Processing of these was unconventional, requiring neither the proteasome nor transporter associated with processing (TAP). However, both epitopes were major targets for circulating effector CD8+ T cells from HLA-A2+ patients with type 1 diabetes. Moreover, cloned preproinsulin signal peptide-specific CD8+ T cells killed human beta cells in vitro. Critically, at high glucose concentration, beta cell presentation of preproinsulin signal epitope increased, as did CTL killing. This study provides direct evidence that autoreactive CTLs are present in the circulation of patients with type 1 diabetes and that they can kill human beta cells. These results also identify a mechanism of self-antigen presentation that is under pathophysiological regulation and could expose insulin-producing beta cells to increasing cytotoxicity at the later stages of the development of clinical diabetes. Our findings suggest that autoreactive CTLs are important targets for immune-based interventions in type 1 diabetes and argue for early, aggressive insulin therapy to preserve remaining beta cells.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A simple method for displaying the hydropathic character of a protein
Kyte, J., & Doolittle, R. F. (1982) · Journal of Molecular Biology · doi:10.1016/0022-2836(82)90515-0 · Cited by 22,843
Perkins, D. N., Pappin, D. J. C., Creasy, D. M., & Cottrell, J. S. (1999) · Electrophoresis · doi:10.1002/(sici)1522-2683(19991201)20:18<3551::aid-elps3551>3.0.co;2-2 · Cited by 8,203
Pruitt, K. D., Tatusova, T., & Maglott, D. R. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkl842 · Cited by 4,481
Mechanisms of Pancreatic β-Cell Death in Type 1 and Type 2 Diabetes
Cnop, M., Welsh, N., Jonas, J.-C., Jörns, A., Lenzen, S., & Eizirik, D. L. (2005) · Diabetes · doi:10.2337/diabetes.54.suppl_2.s97 · Cited by 1,491
Robust associations of four new chromosome regions from genome-wide analyses of type 1 diabetes
Finland, G. O. T. 1. D. I., Todd, J. A., the Wellcome Trust Case Control Consortium, Walker, N. M., Cooper, J. D., Smyth, D. J., Downes, K., Plagnol, V., Bailey, R., Nejentsev, S., et al. (2007) · Nature Genetics · doi:10.1038/ng2068 · Cited by 1,456
Self-citationBottazzo, G. F., Dean, B. M., McNally, J. M., MacKay, E. H., Swift, P. G. F., & Gamble, D. R. (1985) · New England Journal of Medicine · doi:10.1056/nejm198508083130604 · Cited by 932
Visualizing regulatory T cell control of autoimmune responses in nonobese diabetic mice
Tang, Q., Adams, J. Y., Tooley, A. J., Bi, M., Fife, B. T., Serra, P., Santamaria, P., Locksley, R. M., Krummel, M. F., & Bluestone, J. A. (2006) · Nature Immunology · doi:10.1038/ni1289 · Cited by 774
Prime role for an insulin epitope in the development of type 1 diabetes in NOD mice
Nakayama, M., Abiru, N., Moriyama, H., Babaya, N., Liu, E., Miao, D., Yu, L., Wegmann, D. R., Hutton, J. C., Elliott, J. F., et al. (2005) · Nature · doi:10.1038/nature03523 · Cited by 758
Prediction of signal peptides and signal anchors by a hidden Markov model.
Nielsen, H., & Krogh, A. (1998) · PubMed · Cited by 525
HLA-A2 molecules in an antigen-processing mutant cell contain signal sequence-derived peptides
Wei, M. L., & Cresswell, P. (1992) · Nature · doi:10.1038/356443a0 · Cited by 496
Arif, S., Tree, T. I., Astill, T. P., Tremble, J. M., Bishop, A. J., Dayan, C. M., Roep, B. O., & Peakman, M. (2004) · Journal of Clinical Investigation · doi:10.1172/jci19585 · Cited by 479
Self-citationItoh, N., Hanafusa, T., Miyazaki, A., Miyagawa, J., Yamagata, K., Yamamoto, K., Waguri, M., Imagawa, A., Tamura, S., & Inada, M. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116835 · Cited by 346
Dauer, M., Obermaier, B., Herten, J., Haerle, C., Pohl, K., Rothenfusser, S., Schnurr, M., Endres, S., & Eigler, A. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.8.4069 · Cited by 319
Shah, S. C., Malone, J., & Simpson, N. E. (1989) · New England Journal of Medicine · doi:10.1056/nejm198903023200902 · Cited by 317
NKG2D Blockade Prevents Autoimmune Diabetes in NOD Mice
Ogasawara, K., Hamerman, J. A., Ehrlich, L. R., Bour-Jordan, H., Santamaria, P., Bluestone, J. A., & Lanier, L. L. (2004) · Immunity · doi:10.1016/j.immuni.2004.05.008 · Cited by 302
Insulin prophylaxis in individuals at high risk of type 1 diabetes
Keller, R. J., Jackson, R. A., Eisenbarth, G. S., & Eisenbarth, G. (1993) · The Lancet · doi:10.1016/0140-6736(93)91215-8 · Cited by 298
Autoreactive CD8 T cells associated with β cell destruction in type 1 diabetes
Pinkse, G. G. M., Tysma, O. H. M., Bergen, C. A. M., Kester, M. G. D., Ossendorp, F., van Veelen, P. A., Keymeulen, B., Pipeleers, D., Drijfhout, J. W., & Roep, B. O. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0508621102 · Cited by 276
Self-citationAlpha cell function in health and disease: influence of glucagon-like peptide-1
Dunning, B. E., Foley, J. E., & Ahrén, B. (2005) · Diabetologia · doi:10.1007/s00125-005-1878-0 · Cited by 271
Di Lorenzo, T. P., Peakman, M., & Roep, B. O. (2007) · Clinical and Experimental Immunology · doi:10.1111/j.1365-2249.2006.03244.x · Cited by 261
Self-citationHänninen, A., Jalkanen, S., Salmi, M., Toikkanen, S., Nikolakaros, G., & Simell, O. (1992) · Journal of Clinical Investigation · doi:10.1172/jci116067 · Cited by 244
Gerich, J. E., Charles, M. A., & Grodsky, G. M. (1974) · Journal of Clinical Investigation · doi:10.1172/jci107823 · Cited by 230
Somoza, N., Vargas, F., Roura-Mir, C., Vives-Pi, M., Fernández-Figueras, M. T., Ariza, A., Gomis, R., Bragado, R., Martí, M., Jaraquemada, D., et al. (1994) · The Journal of Immunology · doi:10.4049/jimmunol.153.3.1360 · Cited by 210
Autoreactive CD8 T Cells in Organ-Specific Autoimmunity
Liblau, R. S., Wong, F. S., Mars, L. T., & Santamaria, P. (2002) · Immunity · doi:10.1016/s1074-7613(02)00338-2 · Cited by 206
Koppers-Lalic, D., Reits, E. A. J., Ressing, M. E., Lipinska, A. D., Abele, R., Koch, J., Rezende, M. M., Admiraal, P., van Leeuwen, D., Bienkowska-Szewczyk, K., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0501463102 · Cited by 187
CD8+ T-Cell Responses Identify β-Cell Autoimmunity in Human Type 1 Diabetes
Mallone, R., Martinuzzi, E., Blancou, P., Novelli, G., Afonso, G., Dolz, M., Bruno, G., Chaillous, L., Chatenoud, L., Bach, J.-M., et al. (2007) · Diabetes · doi:10.2337/db06-1419 · Cited by 185
Christen, U., McGavern, D. B., Luster, A. D., von Herrath, M. G., & Oldstone, M. B. A. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.12.6838 · Cited by 178
Naturally processed and presented epitopes of the islet cell autoantigen IA-2 eluted from HLA-DR4
Peakman, M., Stevens, E. J., Lohmann, T., Narendran, P., Dromey, J. A., Alexander, A., Tomlinson, A. J., Trucco, M., Gorga, J. C., & Chicz, R. M. (1999) · Journal of Clinical Investigation · doi:10.1172/jci7936 · Cited by 160
Self-citationSelective cytotoxic T-lymphocyte targeting of tumor immune escape variants
van Hall, T., Wolpert, E. Z., van Veelen, P., Laban, S., van der Veer, M., Roseboom, M., Bres, S., Grufman, P., de Ru, A., Meiring, H., et al. (2006) · Nature Medicine · doi:10.1038/nm1381 · Cited by 160
Self-citationStorkus, W. J., Zeh, H. J., Maeurer, M. J., et al. (1993) · The Journal of Immunology · doi:10.4049/jimmunol.151.7.3719 · Cited by 139
Staeva-Vieira, T., Peakman, M., & von Herrath, M. (2007) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2007.03328.x · Cited by 138
Self-citationInitiation of autoimmune diabetes in NOD/Lt mice is MHC class I-dependent
SERREZE, D. V., Chapman, H. D., Varnum, D. S., Gerling, I., Leiter, E. H., & Shultz, L. D. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.158.8.3978 · Cited by 131
Pierce, R. A., Jeffery, E. D., Mutis, T., Golovina, T. N., Kap-Herr, C. V., Wilke, M., Pool, J., Shabanowitz, J., Pettenati, M. J., Eisenlohr, L. C., et al. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.6.3223 · Cited by 126
Britten, C. M., Meyer, R. G., Kreer, T., Drexler, I., Wölfel, T., & Herr, W. (2002) · Journal of Immunological Methods · doi:10.1016/s0022-1759(01)00499-9 · Cited by 124
Toma, A., Haddouk, S., Briand, J., Camoin, L., Gahéry‐Ségard, H., Connan, F., Dubois-Laforgue, D., Caillat‐Zucman, S., Guillet, J., Carel, J., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0504230102 · Cited by 116
Blomberg, K. R., Hautala, R., Lövgren, J., Mukkala, V.-M., Lindqvist, C., & Åkerman, K. E. O. (1996) · Journal of Immunological Methods · doi:10.1016/0022-1759(96)00063-4 · Cited by 110
Beekman, N. J. C. M., van Veelen, P. A., van Hall, T., Neisig, A., Sijts, A. J. A. M., Camps, M. G. M., Kloetzel, P., Neefjes, J., Melief, C. J. M., & OSSENDORP, F. A. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.4.1898 · Cited by 107
Self-citationIntra-islet insulin permits glucose to directly suppress pancreatic A cell function.
Greenbaum, C. J., Havel, P. J., Taborsky, G. J., & Klaff, L. J. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115375 · Cited by 106
Huang, G. C., Zhao, M., Jones, P. M., et al. (2004) · Transplantation · doi:10.1097/01.tp.0000100401.62912.b2 · Cited by 104
Self-citationSnyder, H. L., Bačík, I., Bennink, J. R., Kearns, G. M., Behrens, T. W., Bächi, T., Orłowski, M., & Yewdell, J. W. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.7.1087 · Cited by 101
Standifer, N. E., Ouyang, Q., Panagiotopoulos, C., Verchere, C. B., Tan, R., Greenbaum, C. J., Pihoker, C., & Nepom, G. T. (2006) · Diabetes · doi:10.2337/db06-0066 · Cited by 97
Identification of Insulin Signaling Elements in Human β-Cells
Muller, D. S., Huang, G. C., Amiel, S. A., Jones, P. M., & Persaud, S. J. (2006) · Diabetes · doi:10.2337/db06-0532 · Cited by 88
Self-citationIdentification of a β-Cell-Specific HLA Class I Restricted Epitope in Type 1 Diabetes
Panagiotopoulos, C., Qin, H., Tan, R., & Verchere, C. B. (2003) · Diabetes · doi:10.2337/diabetes.52.11.2647 · Cited by 86
Identification of Naturally Processed HLA-A2—Restricted Proinsulin Epitopes by Reverse Immunology
Hassainya, Y., Garcia‐Pons, F., Kratzer, R., Lindo, V., Greer, F. M., Lemonnier, F. A., Niedermann, G., & Endert, P. V. (2005) · Diabetes · doi:10.2337/diabetes.54.7.2053 · Cited by 74
Marron, M. P., Graser, R. T., Chapman, H. D., & SERREZE, D. V. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.212221199 · Cited by 73
Cellular Immune Activation in Gulf War Veterans
Skowera, A., Hotopf, M. H., Sawicka, E., Varela‐Calviño, R., Unwin, C., Nikolaou, V., Hull, L., Ismail, K., David, A. S., Wessely, S. C., et al. (2004) · Journal of Clinical Immunology · doi:10.1023/b:joci.0000018065.64685.82 · Cited by 70
Self-citationBlum-Tirouvanziam, U., Servis, C., Habluetzel, A., Valmori, D., Men, Y., Esposito, F., Nero, L. D., Holmes, N., Fasel, N. J., & Corradin, G. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.154.8.3922 · Cited by 64
CCR4-bearing T cells participate in autoimmune diabetes
Kim, S. H., Cleary, M. M., Fox, H. S., Chantry, D., & Sarvetnick, N. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0215547 · Cited by 63
CCR4-bearing T cells participate in autoimmune diabetes
Kim, S. H., Cleary, M. M., Fox, H. S., Chantry, D., & Sarvetnick, N. (2002) · Journal of Clinical Investigation · doi:10.1172/jci15547 · Cited by 60
Matsumura, S., Kita, H., He, X.-S., Ansari, A. A., Lian, Z., de Water, J. V., Yamamoto, K., Tsuji, T., Coppel, R. L., Kaplan, M., et al. (2002) · Hepatology · doi:10.1053/jhep.2002.36161 · Cited by 49
Durinovic‐Belló, I., Boehm, B. O., & Ziegler, A. (2002) · Journal of Autoimmunity · doi:10.1006/jaut.2001.0566 · Cited by 47
Humoral and cellular immune responses to proinsulin in adults with newly diagnosed type 1 diabetes
Narendran, P., Williams, A. J. K., Elsegood, K. A., Leech, N., & Dayan, C. M. (2002) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.332 · Cited by 32
Self-citationA busy cell—Endoplasmic reticulum stress in the pancreatic β-cell
Ortsäter, H., & Sjöholm, Å. (2007) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2007.06.006 · Cited by 32
HLA Class I Epitope Discovery in Type 1 Diabetes
Pinkse, G. G. M., Boîtard, C., Tree, T. I. M., Peakman, M., & Roep, B. O. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1375.003 · Cited by 21
Self-citationZhao, M., Christie, M. R., Heaton, N. D., George, S., Amiel, S. A., & Huang, G. C. (2002) · Transplantation · doi:10.1097/00007890-200205150-00015 · Cited by 16
Self-citationSkowera, A., de Jong, E. C., Schuitemaker, J. H. N., Allen, J. S., Wessely, S. C., Griffiths, G., Kapsenberg, M. L., & Peakman, M. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.11.7235 · Cited by 13
Self-citation
Cited by
Type 1 Diabetes: Etiology, Immunology, and Therapeutic Strategies
Van Belle, T. L., Coppieters, K. T., & Von Herrath, M. G. (2011) · Physiological Reviews · doi:10.1152/physrev.00003.2010 · Cited by 1,022
The role of inflammation in insulitis and β-cell loss in type 1 diabetes
Eizirik, D. L., Colli, M. L., & Ortis, F. (2009) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2009.21 · Cited by 1,011
Coppieters, K. T., Dotta, F., Amirian, N., Campbell, P. D., Kay, T. W. H., Atkinson, M. A., Roep, B. O., & von Herrath, M. G. (2012) · Journal of Experimental Medicine · doi:10.1084/jem.20111187 · Cited by 672
Self-citationType 1 diabetes mellitus as a disease of the β-cell (do not blame the immune system?)
Roep, B. O., Thomaidou, S., van Tienhoven, R., & Zaldumbide, A. (2021) · Nature Reviews Endocrinology · doi:10.1038/s41574-020-00443-4 · Cited by 623
Self-citationTodd, J. A. (2010) · Immunity · doi:10.1016/j.immuni.2010.04.001 · Cited by 560
Metadata
- Authors
- Skowera, A., Ellis, R. J., Varela-Calviño, R., Arif, S., Huang, G. C., Van-Krinks, C., Zaremba, A., Rackham, C., Allen, J. S., Tree, T. I. M., Zhao, M., Dayan, C. M., Sewell, A. K., Unger, W., Drijfhout, J. W., Ossendorp, F., Roep, B. O., & Peakman, M.
- Venue
- Journal of Clinical Investigation
- Published
- 2008-09-18
- Volume
- 118
- Issue
- 10
- Pages
- 3390-402
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2162789526
- Cited by
- 362
- References
- 55
- FWCI
- 12.30
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.